Testing the amyloid hypothesis of Alzheimer's disease in vivo.
Gandy
Sam
S
D000544:Alzheimer Disease / Q000235:genetics / Q000503:physiopathology* / Q000628:therapy; D000682:Amyloid / Q000378:metabolism*; D000814:Aniline Compounds; D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D015415:Biomarkers / Q000378:metabolism; D001921:Brain / Q000000981:diagnostic imaging / Q000503:physiopathology*; D020022:Genetic Predisposition to Disease; D006801:Humans; D007116:Immunization, Passive; D007155:Immunologic Factors / Q000627:therapeutic use; D008959:Models, Neurological; D049268:Positron-Emission Tomography; D013844:Thiazoles; D016896:Treatment Outcome
C475519:2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole; D000682:Amyloid; D000814:Aniline Compounds; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D015415:Biomarkers; D007155:Immunologic Factors; D013844:Thiazoles; C545458:bapineuzumab